Evidence map›Paper›PMID 41168698›Full record

ArticleBMC genomics2025

Next-generation sequencing, assembly, annotation, and phylogenomic analysis of the complete mitochondrial genome of the painted lady butterfly Vanessa cardui (Linnaeus, 1758) (Insecta: Lepidoptera: Nymphalidae).

Roohollah Abbasi

Abstract read
In one paragraph

Article in BMC genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Roohollah AbbasiDepartment of Plant and Animal Biology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan, Iran. r.abbasi@bio.ui.ac.ir.ORCID http://orcid.org/0000-0002-3073-190X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVanessa butterflies, with 22 known species with local and cosmopolitan distributions, are good model organisms to study factors that contribute to the distribution and adaptation in the animal kingdom. Here, the complete mitochondrial genome of Vanessa cardui, a cosmopolitan member of Vanessa butterflies in Nymphalidae, was sequenced, assembled, annotated, and characterized.

resultsThe mitogenome was a midsize circular molecule with 15,299 bps containing regular 37 elements, including 13 protein-coding genes (PCGs), 2 rRNA genes, 22 tRNA genes, and an A + T-rich control region. The genes were organized by 11 intergenic and 13 overlapping spaces. The mitogenome showed a GC content of 19 % and a GC skew of -0.191724138, which was the lowest among the other sequenced Vanessa species. Out of 13 PCGs, only 7 start with ATG, and only 9 end with a TAA stop codon. Analysis of Relative Synonymous Codon Usage (RSCU) demonstrated that out of 66 codons, including stop codons, 25 codons were overrepresented, 7 were unbiased, and 34 were underrepresented. The tRNAs with the size range of 60 bps (tRNA

conclusionsStudying Vanessa butterflies with different distribution ranges and their mitogenomes may provide insights into genetic factors influencing species distribution and adaptation. The complete mitogenome data provided better resolution in phylogenetic reconstructions for exploring the evolutionary history of the species.

Indexed as

ButterfliesGenome, MitochondrialGenomicsHigh-Throughput Nucleotide SequencingPhylogenyAnimalsBase CompositionCodon UsageMolecular Sequence AnnotationRNA, RibosomalRNA, TransferRNA, RibosomalRNA, TransferComplete mitochondrial genomeIllumina sequencingLepidopteraMitogenomicsNymphalidaePhylogenomics

Identifiers

PMID41168698
PMCPMC12577240

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.